Literature DB >> 25762486

Single-Session CT-Guided Percutaneous Microwave Ablation of Bilateral Adrenal Gland Hyperplasia Due to Ectopic ACTH Syndrome.

Asha Sarma1, Paul B Shyn2, Mark A Vivian3, Ju-Mei Ng4, Kemal Tuncali5, Jorchen H Lorch6, Sarah N Zaheer7, Michael S Gordon7, Stuart G Silverman5.   

Abstract

Bilateral adrenalectomy is currently the only available treatment for adrenocorticotropic hormone (ACTH)-dependent Cushing's syndrome (ectopic ACTH syndrome) that is refractory to pharmacologic therapy. We describe two patients with refractory ectopic ACTH syndrome who were treated with CT-guided percutaneous microwave ablation of both hyperplastic adrenal glands in a single session: O ne was not a surgical candidate, and the other had undergone unsuccessful surgery. Following the procedure, both patients achieved substantial decreases in serum cortisol, symptomatic improvement, and decreased anti-hypertensive medication requirements.

Entities:  

Keywords:  Adrenal hyperplasia; Cushing’s syndrome; Ectopic ACTH syndrome; Image-guided intervention; Microwave ablation

Mesh:

Year:  2015        PMID: 25762486     DOI: 10.1007/s00270-015-1056-9

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  3 in total

1.  Ectopic ACTH syndrome complicated by multiple opportunistic infections treated with percutaneous ablation of the adrenal glands.

Authors:  Chrystal Chan; James Mark Roberts
Journal:  BMJ Case Rep       Date:  2017-11-14

2.  Percutaneous Bilateral Adrenal Radiofrequency Ablation in Severe Adrenocorticotropic Hormone-dependent Cushing Syndrome.

Authors:  Grzegorz Rosiak; Krzysztof Milczarek; Dariusz Konecki; Maciej Otto; Olgierd Rowinski; Wojciech Zgliczynski
Journal:  J Clin Imaging Sci       Date:  2020-10-03

3.  Utilization of bilateral percutaneous microwave ablation of the adrenal glands in ectopic Cushing's syndrome.

Authors:  Lloyd Petty; Karma Elliott; Keith Quencer; Matthew Wahl; Anu Sharma
Journal:  Radiol Case Rep       Date:  2022-09-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.